Where do Cullinan Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Cullinan Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on assets	-45%-10.3pp	-41.1%-10.8pp	-38.1%-13.1pp	-34.4%—	-34.7%—
Liquidity
Current ratio	10.3×-1.3×	10.2×-3.3×	10.4×-14.0×	9.8×-19.0×	11.6×-8.7×
Quick ratio	10.3×-1.3×	10.2×-3.3×	10.4×-14.0×	9.8×-19.0×	11.6×-8.7×
Cash ratio	2.1×-0.7×	2.3×-0.4×	3.2×-1.1×	2.6×-2.3×	2.8×-0.6×
Leverage
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Valuation
Market capitalization	$1.08B+151%	$611.44M-13.8%	$350.31M-62.0%	$462.67M-38.3%	$442.94M-39.3%
Enterprise value	$1.01B+181%	$525.79M-16.3%	$248.16M-69.8%	$391.37M-38.6%	$368.13M-44.1%
Earnings yield	-19.5%+20.0pp	-36%-12.4pp	-61.9%-46.3pp	-44.7%—	-40.4%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Cullinan Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Cullinan Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.